Sep 18, 2023

News Provided By Share This Article FMI Logo Japanese healthcare equipment service providers are embracing plastic delivery solutions as part of the transition, with a growing adoption rate NEWARK, DELAWARE, UNITED STATES OF AMERICA, September 18, 2023/ EINPresswire.com / -- The global drug delivery solutions market is anticipated to reach a valuation of US$ 107.5 billion in 2023, driven by increasing investments in research and development. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 6.8% between 2023 and 2033, and reaching a total valuation of approximately US$ 207.6 billion by 2033. One of the major factors contributing to the growth of the drug delivery solutions market is the focus on precision medicine and companion diagnostics. The emergence of precision medicine and companion diagnostics has created a need for drug delivery solutions that can be tailored to individual patients based on their genetic makeup, disease characteristics, and treatment response. Personalized therapies require specialized drug delivery systems to deliver the right medication to the right patient at the right time. Another factor driving the growth of the drug delivery solutions market is the favorable government regulations and investments. Governments across the globe are recognizing the importance of innovative drug delivery solutions in improving healthcare outcomes and reducing healthcare costs. They are implementing favorable regulations and policies to encourage the development and adoption of advanced drug delivery technologies. Increased investments in research and development by pharmaceutical companies and venture capitalists are escalating the market growth. Request for a sample of this research report: Request Sample @  https://www.futuremarketinsights.com/reports/sample/rep-gb-14241 Key Takeaways from the Market Study The global drug delivery solutions market was valued at US$ 100.7 billion by 2022-end. From 2018 to 2022, the market demand expanded at a CAGR of 3.4%. India is expected to hold a dominant CAGR of 6.7% during the forecast period. By product type, the bottles segment is expected to constitute a CAGR of 6.7% in 2033. On the basis of application, the injectable segment is expected to dominate the market with a CAGR of 6.6% in 2033. From 2023 to 2033, the drug delivery solutions market is expected to flourish at a CAGR of 6.8%. By 2033, the market value of drug delivery solutions is expected to reach US$ 207.6 billion. Rising demand for biologics & gene therapies, across the globe is a major factor that is expected to propel the growth of drug delivery solutions in the near future, remarks an FMI analyst. Competitive Landscape Amcor Plc Recent Developments: In April 2023, Bayer received approval from the FDA for a new extended-release tablet formulation of its oral contraceptive. The extended-release formulation allows for once-daily dosing, offering improved convenience and compliance for women. In February 2023, Teva announced the launch of a new autoinjector device for the delivery of its biologic therapy for multiple sclerosis. The autoinjector provides a precise and controlled injection, improving patient convenience and adherence to treatment. In October 2022, GlaxoSmithKline announced the FDA approval of a new intranasal formulation of its influenza vaccine, FluLaval. The intranasal formulation offers a needle-free alternative for flu vaccination, particularly for individuals who have a fear of needles. In September 2022, AstraZeneca announced the launch of a new autoinjector device for the administration of its biologic therapy for severe asthma. The autoinjector provides a user-friendly and precise delivery system for patients. Key Segmentations- More Valuable Insights Available Future Market Insights offers an unbiased analysis of the global drug delivery solutions market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033. The packaging team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with the objective of providing authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts. Author By- Ismail Sutaria (Lead Consultant, Packaging and Materials) has over 8 years of experience in market research and consulting in the packaging & materials industry. Ismail’s strength lies in identifying key challenges faced by the client and offering logical and actionable insights to equip the clients with strategic decision-making power. Ismail has been an instrumental part of several transformational consulting assignments. His key skills include competitive benchmarking, opportunity assessment, macroeconomic analysis, and business transformation advisory. Ismail is an MBA holder in Marketing and has a Bachelor’s Degree in Mathematics. Explore Trending Reports of Packaging- Anti-counterfeit Pharmaceutical Packaging Market Size : The global anti-counterfeit pharmaceutical packaging market is expected to grow on an opulent note at the rate of 8.4% between 2022 and 2027. It could reach US$ 149.1 Billion by the year 2027. Pharmaceutical Contract Packaging Market Demand : The global pharmaceutical contract packaging market is forecasted to be valued at US$ 11,586 Million by 2032, up from US$ 5,674 Million in 2022, projecting a CAGR of 7.4% during the forecast period. Ankush Nikam